← Back to headlines
Ligand Pharmaceuticals to Acquire XOMA Royalty, Raises 2026 Guidance
Ligand Pharmaceuticals announced its plan to acquire XOMA Royalty for $39 per share, simultaneously increasing its 2026 guidance and earnings per share outlook.
27 Apr, 23:13 — 27 Apr, 23:13
Sources
Showing 1 of 1 sources
Related Stories
Speedboat Collides with Sailboat in Eretria, Two Injured
2h ago
Penang CM: State remains under control after North Sumatra earthquake tremors
6h ago
Dolly Parton Misses Dollywood Event Due to Health Issues, Fans Concerned
7h ago
Supermarkets including Spar, Dirk and Plus warn of undercooked chicken thigh skewers
16h ago